Melanie Gloria Sells Shares of Immunovant, Inc. $IMVT
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Melanie Gloria, Chief Operating Officer at Immunovant, Inc. ($IMVT), sold 17,714 shares at an average price of $38.31, for a total transaction of $678,603.85. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Immunovant, Inc. Stock Down 5.7%
Shares of Immunovant, Inc. ($IMVT) traded around $38.85 on Saturday, down 5.7% for the day.
Immunovant, Inc. Earnings
Analysts Set New Price Targets
About Immunovant, Inc.
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Get Immunovant, Inc. alerts
New 13F filings, insider trades, and analyst moves on $IMVT, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.